Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Liver Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05104567
What this trial is testing

SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

Who this might be right for
Oesophageal Squamous Cell CarcinomaGastric CancerHepatocellular Carcinoma+2 more
Sanofi 138
Not applicableStudy completedNCT07386639
What this trial is testing

Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer

Who this might be right for
Hepatocellular CarcinomaLiver CancerNeoplasm Metastasis
Tongji University 19,019
Not applicableStudy completedNCT04090645
What this trial is testing

TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer

Who this might be right for
Liver, Cancer of, Non-Resectable
Methodist Health System 187
Early research (Phase 1)Study completedNCT00375245
What this trial is testing

Rapamycin With Grapefruit Juice for Advanced Malignancies

Who this might be right for
TumorsNeoplasm Metastasis
University of Chicago 41
Not applicableEnded earlyNCT02787954
What this trial is testing

Prospective Tumor Response Evaluation

Who this might be right for
Hepatocellular CancerMetastatic Liver Cancer
The University of Texas Health Science Center, Houston 10
Not applicableStudy completedNCT04823715
What this trial is testing

Transarterial Chemoembolization Plus Hypofractionnated Radiotherapy vs. Surgery in Locally Advanced Hepatocellular Carcinoma: an IPTW Comparison

Who this might be right for
Non-metastatic Hepatocellular Carcinoma
Hospices Civils de Lyon 163
Not applicableUnknownNCT05183425
What this trial is testing

Patient-derived Organoids Predicts the Clinical Efficiency of Colorectal Liver Metastasis

Who this might be right for
Explore the Consistency of Drug Sensitivity Between Primary Colorectal Cancer and Liver Metastases
Changhai Hospital 60
Not applicableLooking for participantsNCT06698146
What this trial is testing

Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection

Who this might be right for
Liver Transplant SurgeryColorectal Cancer MetastaticColon Cancer Liver Metastases
Northwestern University 80
Testing effectiveness (Phase 2)Looking for participantsNCT05040360
What this trial is testing

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Who this might be right for
Metastatic Malignant Neoplasm in the LiverPancreatic Neuroendocrine TumorStage I Pancreatic Neuroendocrine Tumor AJCC v8+2 more
SWOG Cancer Research Network 141
Early research (Phase 1)Ended earlyNCT02559024
What this trial is testing

Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Providence Health & Services 4
Not applicableStudy completedNCT00899210
What this trial is testing

Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University Hospital, Grenoble 75
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Not applicableLooking for participantsNCT06227728
What this trial is testing

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Who this might be right for
Non Small Cell Lung CancerBreast CancerColorectal Cancer+4 more
Gene Solutions 50
Testing effectiveness (Phase 2)Study completedNCT00142467
What this trial is testing

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Massachusetts General Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT06555133
What this trial is testing

Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC

Who this might be right for
Colorectal Carcinoma Metastatic in the Liver
Brown University 18
Testing effectiveness (Phase 2)Study completedNCT00103298
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00005616
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05822752
What this trial is testing

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
AbbVie 130
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824856
What this trial is testing

Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoplasm MetastasisLung Metastases+3 more
Sun Yat-sen University 138
Next Page